Anzeige
Meldung des Tages: Ist das DIE Rohstoff-Story des Jahres?

West Pharmaceutical Services Aktie News

Aktie
WKN:  864330 ISIN:  US9553061055 US-Symbol:  WST Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
247,78 $
+0,00 $
0,00%
210,91 € 01:00:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
16,76 Mrd. €
Streubesitz
1,58%
KGV
48,96
Dividende
0,22 $
Dividendenrendite
0,09%
neu: Nachhaltigkeits-Score
32 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 5,16: MK502C
Werbung

West Pharmaceutical Services News

20.01.26 - PR Newswire
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
West Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack PR Newswire
16.01.26 - ARIVA.DE Redaktion
Kaum Veränderung: S&P 500 kommt nicht vom Fleck (6.945 Pkt.)
Kurs­verluste und Kursgewinn halten sich beim S&P 500 zur Stunde in etwa die Waage. Das Börsenbarometer gewinnt derzeit lediglich 0,01 Prozent.
12.01.26 - PR Newswire
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States
AbbVie to Acquire Arizona Manufacturing Facility, Further Strengthening Manufacturing Capabilities in the United States PR Newswire
12.01.26 - PR Newswire
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie
West Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie PR Newswire
06.01.26 - BNP Paribas
West Pharmaceutical Services – Wachstum des Marktes für Abnehmspritzen und andere Faktoren beflügeln das Geschäft
Nach zwei Jahren mit deutlich gesunkener Profitabilität ging es 2025 bei dem US-​Hersteller von Komponenten für injizierbare Medikamente aufwärts. Wie sind die Perspektiven für ...
12.12.25 - PR Newswire
West to Participate in Upcoming Investor Conference
West to Participate in Upcoming Investor Conference PR Newswire
10.12.25 - PR Newswire
West Declares Quarterly Dividend
West Declares Quarterly Dividend PR Newswire
27.10.25 - PR Newswire
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-​level solution for drug delivery PR Newswire
24.10.25 - PR Newswire
West to Participate in Upcoming Investor Conferences
West to Participate in Upcoming Investor Conferences PR Newswire
23.10.25 - PR Newswire
West Reports Third-Quarter 2025 Results
West Reports Third-​Quarter 2025 Results PR Newswire
18.10.25 - wallstreetONLINE Redaktion
Community Rückblick: "Ich hab das Bedürfnis dort morgen hinzufahren und komplett auszurasten"
Die Gerresheimer Aktie crashte in der letzten Woche erneut, nachdem eine Absenkung der Jahres­prognose bekanntgeben wurde. Die Investierten innerhalb der wO-​Community ...
09.10.25 - PR Newswire
West to Host Third-Quarter 2025 Conference Call
West to Host Third-​Quarter 2025 Conference Call PR Newswire
21.08.25 - PR Newswire
West to Participate in Upcoming Investor Conferences in September 2025
West to Participate in Upcoming Investor Conferences in September 2025 PR Newswire
24.07.25 - PR Newswire
West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance
West Announces Second-​Quarter 2025 Results and Fourth-​Quarter 2025 Dividend, Updates Full-Year 2025 Guidance PR Newswire
21.07.25 - PR Newswire
West Welcomes Robert McMahon as Incoming Chief Financial Officer
West Welcomes Robert McMahon as Incoming Chief Financial Officer PR Newswire
08.07.25 - PR Newswire
West to Host Second-Quarter 2025 Conference Call
West to Host Second-​Quarter 2025 Conference Call PR Newswire
07.07.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming ...
07.07.25 - PR Newswire
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm
WST Investors Have Opportunity to Lead West Pharmaceutical Services, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
07.07.25 - PR Newswire
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact The Gross Law Firm
Class Action Filed Against West Pharmaceutical Services, Inc. (WST) Seeking Recovery for Investors - Contact The Gross Law Firm PR Newswire
07.07.25 - PR Newswire
WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST
WST Shareholders Have the Right to Lead the West Pharmaceutical Services, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - WST PR Newswire

Newssuche

Videos

newspaper
22.01.26 -33,33%
Trading Insights vom 22.01.26
Preisschock bei Erdgas! Was sind die Gründe, wie geht man damit um? Gold auf neuem Allzeithoch: wie ... Mehr »